Article

Visual prognosis appears generally good after PPV for retained lens material

An analysis of visual outcomes in a contemporary series of cataract surgery eyes that underwent pars plana vitrectomy (PPV) for retained lens material indicates these complicated cases tend to do well, said Lawrence Y. Ho, MD.

An analysis of visual outcomes in a contemporary series of cataract surgery eyes that underwent parsplana vitrectomy (PPV) for retained lens material indicates these complicated cases tend to do well,said Lawrence Y. Ho, MD.

Dr. Ho reported the findings from a retrospective review that included analyses for predictors ofgood and poor visual outcomes. The series included 166 consecutive cases from a 6-year periodextending from January 2001 to January 2007. Follow-up exceeded 6 months in more than 80% of eyes.The visual results showed 72% of eyes achieved vision of 20/40 or better while only 10.8% ended upwith vision of 20/200 or worse.

"The outcomes in this series surpass those in prior large series that showed only 58% of patients hadvision of 20/40 or better while almost 18% saw 20/200 or worse. We believe improvements in both phacotechnology and vitrectomy combined with earlier detection of treatment complications, such as CMEwith more widespread use of OCT, may account for the difference. However, this warrants furtherinvestigation," said Dr. Ho.

Predictors of vision outcomes were examined in a multivariate analysis. Better presenting vision,insertion of a posterior chamber IOL, and absence of preoperative eye disease were associated with agood vision outcome.

Development of glaucoma and presence of preexisting eye disease were associated with a poor visionoutcome while anterior vitrectomy at the time of cataract surgery and sulcus lens placement atcataract surgery had protective value.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.